Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of FPHAX will - over the next 2 Weeks and hit - by . In that time frame, FPHAX's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
FPHAX shares fell -0.94% in Thursday, September 10, 2026's trading session, dropping from a previous close of $34.22 to move at $33.90. The stock demonstrated notable intraday movement (see FPHAX's key stats for a full breakdown), fluctuating between $33.90 and $34.22, a +0.94% trading range. While recent weeks have seen some volatility, FPHAX has managed to secure a -5.04% drop over the past 2 weeks. The downward price movement was accompanied by remained steady trading volume, with approximately 0 shares changing hands, 0 fewer than the previous session. This amounted to $0.00 in total market activity.
Will FPHAX Continue Its Trend?
According to analyst ratings and projections for FPHAX, Fidelity Select Pharmaceuticals shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for FPHAX currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 18 negative trading days within the past 30 sessions. Based on the FPHAX stock forecast, now is not the best time to buy FPHAX stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on FPHAX covering social and institutional perspectives.
FPHAX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into FPHAX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 33.29% to 44.53%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 50.30%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.11%, maintains a neutral outlook for the long term. Insights into FPHAX's shareholder base show how institutional investors are positioning themselves during these momentum shifts

